Comparison of the effectiveness of topical minoxidl and cetirizine in androgenetic alopecia

Phase 3

• Conditions: Androgenetic Alopecia.; Androgenic alopecia

• Registration Number: IRCT20230308057655N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

All patient with androgenetic alopecia aged 18 to 50
Patient who are willing to participate in trial

Exclusion Criteria

Patient with other types of alopecia
Any serious systemic disease
Patient who have had a history of hair transplantation in the past
History of sensitivity to cetirizine and minoxidil
Systemic steroid use for more than 14 days in the last 2 monthes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The increase in density and thickness of hair. Timepoint: before the start of treatment and 4 months after the start of treatment. Method of measurement: Trichogram and standard photography in 4 views.

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction score, doctor satisfaction score. Timepoint: The beginning of the study and 4 months after the start of the study. Method of measurement: A 7-point questionnaire to check the level of patient and doctor satisfaction.